JLK,Inc. Stock

Equities

A322510

KR7322510009

Software

End-of-day quote Korea S.E. 06:00:00 2024-05-16 pm EDT 5-day change 1st Jan Change
15,210 KRW +19.20% Intraday chart for JLK,Inc. +9.42% -30.71%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 3.42B 2.52M Sales 2023 2.49B 1.84M Capitalization 348B 257M
Net income 2022 -9.01B -6.65M Net income 2023 -7.32B -5.4M EV / Sales 2022 16.3 x
Net Debt 2022 8.31B 6.13M Net Debt 2023 11.95B 8.82M EV / Sales 2023 144 x
P/E ratio 2022
-5.21 x
P/E ratio 2023
-46.8 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 74.21%
More Fundamentals * Assessed data
Dynamic Chart
1 day+19.20%
1 week+9.42%
Current month+26.86%
1 month+59.10%
3 months-1.23%
6 months-36.23%
Current year-30.71%
More quotes
1 week
12 450.00
Extreme 12450
15 880.00
1 month
8 990.00
Extreme 8990
15 880.00
Current year
8 990.00
Extreme 8990
24 900.00
1 year
7 490.00
Extreme 7490
39 050.00
3 years
3 100.00
Extreme 3100
39 050.00
5 years
3 100.00
Extreme 3100
39 050.00
10 years
3 100.00
Extreme 3100
39 050.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 -
Founder 59 14-02-17
Members of the board TitleAgeSince
Founder 59 14-02-17
Chief Executive Officer 47 -
More insiders
Date Price Change Volume
24-05-20 14,600 -4.01% 829,365
24-05-17 15,210 +19.20% 4,532,648
24-05-16 12,760 -5.13% 298,928
24-05-14 13,450 +4.83% 494,095
24-05-13 12,830 -7.70% 517,074

End-of-day quote Korea S.E., May 16, 2024

More quotes
JLK Inc, formerly JLK Inspection Inc, is a Korea-based company principally engaged in the development of artificial intelligence (AI) software. The Company develops software including AI medical analysis solutions, AI industry and security analysis solutions and others. Medical diagnostic platforms consist of AI medical systems, AI quantitative analysis platforms, AI remote platforms, AI medical diagnostic platforms, among others.
More about the company
  1. Stock Market
  2. Equities
  3. A322510 Stock
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW